FY-2019 Top 20 Commercially Successful Inventions
(based on royalties on product sales)
| VACCINES & THERAPEUTICS |
| Rank | | | |
| 1 | Novel Protease Inhibitor for Treatment of Drug-Resistant HIV-1 | Erickson, et al. | NCI |
| 2 | Nutritional Supplement to Treat Macular Degeneration | Ferris, et al. | NEI |
| 3 | Proteosome Inhibitor for Treatment of Multiple Myeloma | Gupta, et al. | NCI |
| 4 | HPV Vaccines Based Upon Recombinant Papillomavirus Capsid Proteins | Lowy et al. | NCI |
| 6 | Pox Virus Based Veterinary Vaccines | Moss, et al. | NIAID |
| 7 | Ulipristal Acetate Treatment of Uterine Fibroids | Nieman, et al. | NICHD |
| 9 | Daclizumab Treatment of Multiple Sclerosis | Bielekova, et al. | NINDS |
| 10 | Palifermin for Treatment of Oral Mucositis | Rubin, et al. | NCI |
| 16 | Dengue Virus Vaccine | Lai, et al. | NCI |
| 15 | Multivalent Human-Bovine Rotavirus Vaccine | Kapikian, et al. | NIAID |
| 19 | Japanese Encephalitis Virus Vaccine | Lai, et al. | NIAID |
| | | | |
| DIAGNOSTICS |
| Rank | | | |
| 5 | HIV-1 Diagnostic Test Kits | Gallo, et al. | NCI |
| 11 | HIV-1 Genotyping Assays | Medabalimi, et al. | NCI |
| 13 | DNA Probe for Breast Cancer Diagnosis (HER-2) | King, et al. | NCI |
| 18 | Norwalk-like Virus ELISA Assay | Green, et al. | NIAID |
| | | | |
| INSTRUMENTATION & DEVICES |
| Rank | | | |
| 20 | Transcranial Magnetic Stimulation System | Zangen, et al. | NIDA |
| | | | |
| RESEARCH MATERIALS |
| Rank | | | |
| 8 | Digital PCR | Silver, et al. | NIAID |
| 12 | Cell Lines Established from Certain Human Tumors | Oie, et al. | NCI |
| 14 | Murine Colon 38 Cell Line | Hollingshead, et al. | NCI |
| 17 | Ovarian Tumor Antigen | Hamilton, et al. | NCI |
